Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?)

Leukemia Research

Volumn 47, Issue , 2016, Pages 63-69

  Bennett, John M ^a   Tuechler, Heinz ^b   Aul, Carlo ^c   Strupp, Corinna ^d   Germing, Ulrich ^d  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b HANUSCH HOSPITAL   (Austria)

^c ST JOHANNES HOSPITAL   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Acute myeloid leukemias (AML); Myelodysplastic syndromes (MDS)

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CELL COUNT; DISEASE CLASSIFICATION; ERYTHROID PRECURSOR CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MYELOBLAST; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; ACUTE MYELOID LEUKEMIA; BLAST CELL CRISIS; BONE MARROW; DISEASE COURSE; PATHOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REGISTER; YOUNG ADULT;

ADULT; BLAST CRISIS; BONE MARROW; CELL COUNT; DISEASE PROGRESSION; ERYTHROID PRECURSOR CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84974573477     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2016.05.006     Document Type: Article

References (16)

1. Di. Guglielmo, G. Richerche di ematologia., I, un caso di eritroleucemia: megacariociti in circolo e loro funzione piastrinopoieticoFolia Medica (Pavia).13:386 (1917).
2. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the acute leukaemias French-American-British (FAB) co-operative group. Br. J. Haematol. 1976, 33:451-458.
3. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. 1985 proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Annals Intern. Med. 1985, 103:620-625.
4. Brunning R.D., Orazi A., Germing U., Le Beau M.M., Porwit A., Baum I. Myelodysplastic syndromes/neoplasms, overview. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 87-102. IARC, Lyon. S.H. Swerdlow, E. Campo, N. Lee Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
5. Arber D.A., Orazi A., Hasserjian R., et al. Perspective: the 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemias. Blood 2016, (Prepublished on line April 11, 2016).
6. Germing U., Gattermann N., Strupp C., Aivado M., Aul C. Validation of he WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk. Res. 2000, 24:983-992.
7. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 87-102. IARC, Lyon. N. Lee Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
8. Greenberg P.L., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079-2088.
9. Greenberg P.L., Tuechler H., Schanz J., Sanz G., Garcia-Manero G., Sole F., et al. Revised international prognostic scoring system (IPSS-R) for myelodysplastic syndromes. Blood 2012, 120:2454-2465.
10. Harrell Frank E With Contributions from Charles Dupont and Many Others 2015 Hmisc: Harrell Miscellaneous. R Package Version 3 17-1 https://CRAN.R-project.org/package=Hmisc.
11. R Core Team R: A Language and Environment for Statistical Computing R Foundation for Statistical Computing, Vienna, Austria. URL 2015, https://www.R-project.org/.
12. Therneau T. A Package for Survival Analysis in S_ Version 2.38, URL 2015, http://CRAN.R-project.org/package=survival.
13. Malcovati L., Germing U., Kuendgen A., et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J. Clin. Oncol. 2007, 25(23):3503-3510.
14. Kantarjian H., O'Brien S., Ravandi F., et al. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 2008, 113(6):1351-1361.
15. Park S., Picard F., et al. Erythroleukemia: a comparison between the previous FAB approach and the WHO classification. Leuk. Res. 2002, 26:423-429.
16. Wang S.A., Tang G., Fadare O., Hao S., Raza A., Woda B.A., Hasserjian R.P. Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from non erythroid rather than total marrow cells provides superior risk stratification. Mod. Pathol. 2008, 21:1394-1402.